Though considered a rare disorder, VHL affects approximately 1 in 36,000 people worldwide. The prevalence can vary by region, but the syndrome does not show a significant predilection for any specific gender or ethnic group. Given its rarity, VHL often remains underdiagnosed, complicating efforts to accurately ascertain its true epidemiological footprint.
